Evidence map›Paper›PMID 40276253›Full record

ReviewDiscover psychology2025

Similarities and important distinctions between drug and behavioral intervention development.

Hannah M Fisher, Joseph G Winger, Gregory P Samsa, Tamara J Somers

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Discover psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hannah M FisherDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC USA.
Joseph G WingerDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC USA.
Gregory P SamsaDuke Cancer Institute, Durham, NC USA.
Tamara J SomersDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been a proliferation in behavioral intervention development due to guidelines recommending their use for managing common, distressing, and interfering symptoms (e.g., insomnia, pain, fatigue) resulting from medical disease (e.g., cancer) and its treatment. Several models of behavioral intervention development exist (e.g., Stage Model, ORBIT). In this review, we focus on the National Institute of Health (NIH) Stage Model for Behavioral Intervention Development because it offers the closest analogue to the formalized drug development process. This review compares the phases of drug development to the six stages of the Stage Model for behavioral intervention development to assist investigators in understanding similarities and differences in terminology (i.e.,

Indexed as

Behavioral intervention developmentBehavioral symptom managementDrug developmentHematologic cancerInsomniaStage model

Identifiers

PMID40276253
PMCPMC12014819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.